MOUNTAIN VIEW, Calif., Dec. 17, 2010 (GLOBE NEWSWIRE) -- Complete Genomics, Inc. (Nasdaq:GNOM) today announced its unaudited financial results for the quarter ended September 30, 2010. These results were previously summarized in the prospectus relating to the Company's initial public offering, which closed on November 16, 2010. Revenue in the third quarter of 2010 was $4.2 million, compared to no revenue during the third quarter of 2009.
